FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, namely to a method for preparing solid pharmaceutical dosage forms containing a quinolone compound. E.g. the method under the invention involves using an extruder, particularly a turn-screw extruder designed for granulation from the quinolone compound mixed with a granulation excipient.
EFFECT: developing the method for preparing the solid pharmaceutical dosage forms containing the quinolone compound.
6 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR | 2006 |
|
RU2404775C2 |
| COMPOSITIONS OF QUINOLINONES | 2006 |
|
RU2433826C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING NILOTINIB OR ITS SALTS | 2007 |
|
RU2469707C2 |
| BENZIMIDAZOLYLPYRIDYL ESTER SALTS AND COMPOSITIONS CONTAINING THEM | 2007 |
|
RU2457206C2 |
| STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING SUBSTITUTED PYRIDYLSULFINYLBENZIMIDAZOLE | 1998 |
|
RU2216321C2 |
| CRYSTALLINE FORMS AND TWO SOLVATE FORMS OF LACTIC ACID SALTS 4-AMINO-5-FLUORINE-3-[5-(4-METHYLPIPERAZIN-1-YL)-1-H-BENZIMIDAZOL-2-YL]QUINOLINE-2(1H)ONE | 2009 |
|
RU2497820C2 |
| PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5) ANTAGONISTS | 2011 |
|
RU2602955C2 |
| METHOD OF OBTAINING COMPOSITIONS BY EXTRUSION OF RESISTANT TO PRESSING PHARMACEUTICAL SUBSTANCES | 2006 |
|
RU2405539C2 |
| CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
| METHOD FOR PREPARING SOLID DISPERSIONS OF HIGH CRYSTALLINE THERAPEUTIC COMPOUNDS | 2007 |
|
RU2454220C2 |
